1
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
------------------------
Date of Report (Date of earliest event reported): Not applicable
CVS CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 1-1011 05-0494040
(STATE OR OTHER JURISDICTION (COMMISSION FILE NUMBER) (IRS EMPLOYER IDENTIFICATION
OF INCORPORATION) NO.)
1 CVS DRIVE
WOONSOCKET, RHODE ISLAND 02895
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(401) 765-1500
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
================================================================================
2
ITEM 5. OTHER EVENTS
The supplemental consolidated financial statements of CVS Corporation as of
December 31, 1996 and 1995 and for each of the years in the three-year period
ended December 31, 1996 and as of and for the three months ended March 29, 1997
and March 30, 1996, together with the related supplemental schedule and
supplemental Management's Discussion and Analysis of Financial Condition and
Results of Operations, in each case as restated for the merger of CVS
Corporation and Revco D.S., Inc. (which was consummated on May 29, 1997) which
has been accounted for as a pooling of interests under Accounting Principles
Board Opinion No. 16, are filed as an exhibit hereto and incorporated by
reference herein.
ITEM 7. FINANCIAL STATEMENTS, PRO-FORMA FINANCIAL INFORMATION AND EXHIBITS
c. Exhibits.
11.1 Supplemental Statement re: Computation of Net Earnings Per Share for each of
the years in the three-year period ended December 31, 1996
11.2 Supplemental Statement re: Computation of Net Earnings Per Share for the
three months ended March 29, 1997 and March 30, 1996
12 Supplemental Statement re: Computation of Ratio of Earnings to Fixed Charges
23.1 Consent of KPMG Peat Marwick LLP
23.2 Consent of Arthur Andersen LLP
27.1 Supplemental Restated Financial Data Schedule -- March 29, 1997
27.2 Supplemental Restated Financial Data Schedule -- December 31, 1996
27.3 Supplemental Restated Financial Data Schedule -- September 28, 1996
27.4 Supplemental Restated Financial Data Schedule -- June 29, 1996
27.5 Supplemental Restated Financial Data Schedule -- March 30, 1996
27.6 Supplemental Restated Financial Data Schedule -- December 31, 1995
27.7 Supplemental Restated Financial Data Schedule -- September 30, 1995
27.8 Supplemental Restated Financial Data Schedule -- July 1, 1995
27.9 Supplemental Restated Financial Data Schedule -- April 1, 1995
27.10 Supplemental Restated Financial Data Schedule -- December 31, 1994
99.1 Supplemental consolidated financial statements of CVS Corporation as of
December 31, 1996 and 1995 and for each of the years in the three-year period
ended December 31, 1996, together with the related supplemental Management's
Discussion and Analysis of Financial Condition and Results of Operations, in
each case as restated for the merger of CVS Corporation and Revco D.S. Inc.,
(which was consummated on May 29, 1997) which has been accounted for as a
pooling of interests under Accounting Principles Board Opinion No. 16.
99.2 Supplemental consolidated condensed financial statements of CVS Corporation
as of and for the three months ended March 29, 1997 and March 30, 1996
together with the related supplemental Management's Discussion and Analysis
of Financial Condition and Results of Operations, in each case as restated
for the merger of CVS Corporation and Revco D.S. Inc., (which was consummated
on May 29, 1997) which has been accounted for as a pooling of interests under
Accounting Principles Board Opinion No.16.
99.3 Supplemental Schedule II -- Valuation and Qualifying Accounts
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CVS CORPORATION
By: /s/ CHARLES C. CONAWAY
--------------------------------------
Name: Charles C. Conaway
Title: Executive Vice President
and Chief Financial Officer
Dated: July 17, 1997
4
INDEX TO EXHIBITS
EXHIBIT NO. DESCRIPTION
- ----------- ----------------------------------------------------------------------------------
11.1 Supplemental Statement re: Computation of Net Earnings Per Share for each of the
years in the three-year period ended December 31, 1996
11.2 Supplemental Statement re: Computation of Net Earnings Per Share for the three
months ended March 29, 1997 and March 30, 1996
12 Supplemental Statement re: Computation of Ratio of Earnings to Fixed Charges
23.1 Consent of KPMG Peat Marwick LLP
23.2 Consent of Arthur Andersen LLP
27.1 Supplemental Restated Financial Data Schedule -- March 29, 1997
27.2 Supplemental Restated Financial Data Schedule -- December 31, 1996
27.3 Supplemental Restated Financial Data Schedule -- September 28, 1996
27.4 Supplemental Restated Financial Data Schedule -- June 29, 1996
27.5 Supplemental Restated Financial Data Schedule -- March 30, 1996
27.6 Supplemental Restated Financial Data Schedule -- December 31, 1995
27.7 Supplemental Restated Financial Data Schedule -- September 30, 1995
27.8 Supplemental Restated Financial Data Schedule -- July 1, 1995
27.9 Supplemental Restated Financial Data Schedule -- April 1, 1995
27.10 Supplemental Restated Financial Data Schedule -- December 31, 1994
99.1 Supplemental consolidated financial statements of CVS Corporation as of December
31, 1996 and 1995 and for each of the years in the three-year period ended
December 31, 1996, together with the related supplemental Management's Discussion
and Analysis of Financial Condition and Results of Operations, in each case as
restated for the merger of CVS Corporation and Revco D.S. Inc., (which was
consummated on May 29, 1997) which has been accounted for as a pooling of
interests under Accounting Principles Board Opinion No.16.
99.2 Supplemental consolidated condensed financial statements of CVS Corporation as of
and for the three months ended March 29, 1997 and March 30, 1996, together with
the related supplemental Management's Discussion and Analysis of Financial
Condition and Results of Operations, in each case as restated for the merger of
CVS Corporation and Revco D.S. Inc., (which was consummated on May 29, 1997) which
has been accounted for as a pooling of interests under Accounting Principles Board
Opinion No.16.
99.3 Supplemental Schedule II -- Valuation and Qualifying Accounts